Gottlieb’s first 100 days . . .

Stakeholders Praise Gottlieb For Keeping The Agency On Track

/ August 18, 2017 at 3:25 PM
Friday (Aug. 18) marked Scott Gottlieb’s 100th day as the 23rd FDA commissioner. In a time of political uncertainty, Gottlieb has, for most stakeholders, provided a sense of stability -- regardless of one’s vision for where the agency should move in the future. The nomination of Gottlieb was not free of controversy. Liberal Democrats and consumer advocacy groups slammed Gottlieb for his previous ties to industry, while others, including Senate health committee ranking Democrat Patty Murray (WA) and former FDA...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.